Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Margin

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -7.389.276.3123.8719.63

What is the latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES is -7.38 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-7.38
Mar20239.27
Mar20226.31
Mar202123.87
Mar202019.63

How is Core EBITDA Margin of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2024 -7.38
Negative
Mar2023 9.27
46.91
Mar2022 6.31
-73.57
Mar2021 23.87
21.60
Mar2020 19.63 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Margin ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹3,045.9 Cr -9.9% -15.2% 72.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-9.9%

-15.2%

72.4%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses